Naftifin cream 10 mg/g tube of 15 g




Naftifine cream is used for the topical treatment of fungal infections caused by pathogens sensitive to naftifine, such as:
Fungal infections of the skin and skin folds; interdigital mycoses; fungal infections of the nails (onychomycoses); cutaneous candidiasis; tinea versicolor; inflammatory dermatomycoses, with or without itching.Composition
The active substance is naftifine hydrochloride (1 g of the drug contains 10 mg of naftifine hydrochloride).
Excipients: cetostearyl alcohol, isopropyl myristate, polysorbate 60, cetyl palmitate, sorbitan sesquioleate, benzyl alcohol, sodium hydroxide, purified water.
Contraindication
hypersensitivity to naftifine or to the excipients of the drug; the drug should not be applied to the wound surface; do not use to treat the eyes.Method of application
Naftifine cream should be applied to the affected skin surface and adjacent areas once a day after it has been thoroughly cleaned and dried, capturing approximately 1 cm of healthy skin around the edges of the affected area.
Duration of treatment:
for dermatomycoses - 2-4 weeks (if necessary - up to 8 weeks); for candidiasis - 4 weeks; for nail infections - up to 6 months.For fungal nail diseases, the drug is recommended to be used 2 times a day. Before the first use, it is necessary to remove as much of the affected part of the nail as possible with scissors or a nail file (to facilitate this procedure, on the recommendation of a doctor, the nails can be treated with a special softening agent).
To prevent relapse, treatment should be continued for at least 2 weeks after the main symptoms of the disease have disappeared.
Application features
Pregnant women
The drug can be used during pregnancy and breastfeeding only if necessary after a careful assessment of the benefit/risk ratio, which is determined by the doctor.
Breastfeeding women should avoid contact with the skin and digestive tract of the baby.
Children
There is insufficient data on the efficacy and safety of the drug in children, so it is not recommended to prescribe it to patients in this age category.
Drivers
The drug does not affect the reaction speed when driving vehicles or other mechanisms.
Overdose
Acute overdose with topical application of naftifine has not been observed.
Systemic intoxication with external use of the drug is unlikely, since a small amount of the active substance is absorbed through the skin.
In case of accidental ingestion of the drug, symptomatic treatment should be initiated.
Side effects
In rare cases, local reactions may occur: dry skin, redness and burning, erythema, itching, local irritation. Side effects are usually reversible and do not require discontinuation of the drug.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.
Shelf life - 2 years from the date of manufacture of the drug in bulk packaging.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.